Critical role of L-selectin and histamine H4 receptor in zymosan-induced neutrophil recruitment from the bone marrow: Comparison with carrageenan

被引:32
作者
Takeshita, K [1 ]
Bacon, KB [1 ]
Gantner, F [1 ]
机构
[1] Bayer Yakuhin Ltd, Res Ctr Kyoto, Resp Dis Res, Kizu, Kyoto 6190216, Japan
关键词
D O I
10.1124/jpet.103.063776
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Zymosan and carrageenan represent two inflammatory stimuli leading to significant neutrophilia when injected into mice. Despite several similarities between the two proinflammatory agents, the mechanisms leading to neutrophil influx into the site of stimulus injection are unclear. As demonstrated by antibody (Ab) studies directed against adhesion molecules, L-selectin was pivotal for zymosan-induced but not carrageenan-induced pleurisy. Zymosan but not carrageenan injection into the pleural cavity caused blood neutrophilia and significant release of neutrophils from the bone marrow, events that were inhibited by anti-L-selectin but not anti-Mac-1 Ab pretreatment. Pertussis toxin, known to regulate cell efflux, abrogated both zymosan- and carrageenan-induced pleurisy, but only zymosan- induced neutrophil release from the bone marrow. Dexamethasone, known to inhibit pleurisy induced by either stimulus, had no effect on bone marrow neutrophil numbers. The G(i/o) G protein-coupled H-4 histamine receptor is highly expressed in the bone marrow and on leukocytes and plays an important role in zymosan-induced pleurisy in vivo. Zymosan-triggered neutrophil release from bone marrow was abrogated by pretreatment of mice with thioperamide, a known H-3/4 receptor antagonist, whereas H-1 and H-2 receptor antagonists had no effect. Moreover, histamine itself, when injected intravenously, led to a similar time- and dose-dependent decrease of neutrophil numbers in the bone marrow that was inhibited by thioperamide. Because the H-3 receptor is not expressed on neutrophils, these findings indicate that both H-4 and L-selectin regulate zymosan-induced neutrophil release from bone marrow and subsequent infiltration in the pleurisy model.
引用
收藏
页码:272 / 280
页数:9
相关论文
共 33 条
[1]   P-selectin mediates neutrophil adhesion to endothelial cell borders [J].
Burns, AR ;
Bowden, RA ;
Abe, Y ;
Walker, DC ;
Simon, SI ;
Entman, ML ;
Smith, CW .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (03) :299-306
[2]   EFFECT OF SELECTED ANTIINFLAMMATORY AGENTS AND OTHER DRUGS ON ZYMOSAN, ARACHIDONIC-ACID, PAF AND CARRAGEENAN INDUCED PAW EDEMA IN THE MOUSE [J].
CALHOUN, W ;
CHANG, J ;
CARLSON, RP .
AGENTS AND ACTIONS, 1987, 21 (3-4) :306-309
[3]   5-Lipoxygenase knockout mice exhibit a resistance to pleurisy and lung injury caused by carrageenan [J].
Cuzzocrea, S ;
Rossi, A ;
Serraino, I ;
Mazzon, E ;
Di Paola, R ;
Dugo, L ;
Genovese, T ;
Calabrò, B ;
Caputi, AP ;
Sautebin, L .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 73 (06) :739-746
[4]   MAST-CELL AMINES AND THE EDEMA INDUCED BY ZYMOSAN AND CARRAGEENANS IN RATS [J].
DAMAS, J ;
REMACLEVOLON, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 121 (03) :367-376
[5]   POST-CAPILLARY VENULES IN THE MILKY SPOTS OF THE GREATER OMENTUM ARE THE MAJOR SITE OF PLASMA-PROTEIN AND LEUKOCYTE EXTRAVASATION IN RODENT MODELS OF PERITONITIS [J].
DOHERTY, NS ;
GRIFFITHS, RJ ;
HAKKINEN, JP ;
SCAMPOLI, DN ;
MILICI, AJ .
INFLAMMATION RESEARCH, 1995, 44 (04) :169-177
[6]   CAPTOPRIL UNCOVERS KININ-DEPENDENT RELEASE OF ARACHIDONIC-ACID METABOLITES IN CARRAGEENIN-INDUCED RAT PLEURISY [J].
DOZEN, M ;
YAMAKI, K ;
OHISHI, S .
JAPANESE JOURNAL OF PHARMACOLOGY, 1989, 51 (01) :101-105
[7]   Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines [J].
Ebnet, K ;
Vestweber, D .
HISTOCHEMISTRY AND CELL BIOLOGY, 1999, 112 (01) :1-23
[8]   HISTAMINE INHIBITS CELL SPREADING AND C3BI RECEPTOR CLUSTERING AND DIMINISHES HYDROGEN-PEROXIDE PRODUCTION BY ADHERENT HUMAN NEUTROPHILS [J].
FRANCIS, JW ;
TODD, RF ;
BOXER, LA ;
PETTY, HR .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 147 (01) :128-137
[9]   Histamine H4 and H2 receptors control histamine-induced interleukin-16 release from human CD8+ T cells [J].
Gantner, F ;
Sakai, K ;
Tusche, MW ;
Cruikshank, WW ;
Center, DM ;
Bacon, KB .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (01) :300-307
[10]  
Hornquist CE, 1997, J IMMUNOL, V158, P1068